OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all 5 treatment cycles in PREEMPT

Benzer Materyaller

• OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program
  Yazar:: Aurora, SK, ve diğerleri
  Baskı/Yayın Bilgisi: (2014)
• The percent of chronic migraine patients who responded to onabotulinumtoxinA treatment per treatment cycle in the PREEMPT clinical program
  Yazar:: Silberstein, S, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients without medication overuse
  Yazar:: Diener, HC, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Per cent of patients with chronic migraine who responded per onabotulinumtoxinA treatment cycle: PREEMPT
  Yazar:: Silberstein, Stephen D, ve diğerleri
  Baskı/Yayın Bilgisi: (2015)
• Headache symptoms of the PREEMPT population
  Yazar:: Dodick, DW, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)